Category: Study design
Labels: results, rationale
Related questions: NA
Creation date and Author: Unknown, November 5th 2024
Last Update and Author: Astrid C., June 23rd 2025
The raw omics data of the patients will be provided by CURE51 to the partner centers. The manner in which this data is used will be determined by the Principal Investigator at each site. Clinical research may be conducted independently based on this data, and any resulting findings may be communicated to the patient at the discretion of the PI.